Khan Najat - Insider Non-Derivative Transactions at RECURSION PHARMACEUTICALS, INC. (RXRX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 1, 2024, Khan Najat's relationship to RECURSION PHARMACEUTICALS, INC. (RXRX) is Director,Officer (Chief R&D Commercial Officer), and currently has 496,972 shares of Class A Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RXRX insiders.
Data Source: SEC.
Khan Najat - Insider Non-Derivative Transactions at RXRX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 2, 2024 | Acquisition -- (Class A Common Stock) | 496972 | 0 | 496972 |